You have a BMI of 27 or higher plus a weight-related comorbidity approved by Cigna, including (but not limited to) hypertension, Type 2 diabetes, obstructive sleep apnea, and CV disease
These occurred in 6.5% of participants on Wegovy and 8.0% on placebo, a 20% relative risk reduction
Synapse database indicates that 3 patents have been filed for this peptide: GEP44 elicits Y1-R antagonist-controlled, GLP-1R-dependent stimulation of insulin secretion in both rat and human pancreatic islets, thus revealing the counteracting effects of Y1-R and GLP-1R agonism
To view or add a comment, sign in The Patent Cliff: Why the "Everything Drug" is a South African Economic Catalyst The global conversation around GLP-1 drugs (like Ozempic and Mounjaro) has shifted from weight loss to a fundamental macroeconomic disruptor: The Longevity Dividend
Iran War Spokane Wildfires World Politics Entertainment HealthWatch MoneyWatch Crime Space Sports Brand Studio The Free Press Local News Atlanta Baltimore Bay Area Boston Chicago Colorado Detroit Los Angeles Miami Minnesota New York Philadelphia Pittsburgh Sacramento Texas Live CBS News 24/7 Baltimore Bay Area Boston Chicago Colorado Detroit Los Angeles Miami Minnesota New York Philadelphia Pittsburgh Sacramento Texas 48 Hours 60 Minutes Shows 48 Hours 60 Minutes CBS Evening News CBS Mornings CBS Morning News CBS Reports CBS Saturday Morning The Daily Report The Dish Face the Nation Sunday Morning The Takeout Things That Matter The Uplift CBS News Investigates CBS News Confirmed Podcasts Newsletters Download Our App CBS News Team Executive Team Brand Studio Paramount+ Join Our Talent Community RSS Feeds Boston | News Weather Sports Video WBZ Features All News Health I-Team Politics Education Business Consumer Entertainment NEXT Weather Forecast Radar & Maps School Closings School Visits Earth Matters Share Photos and Videos Join Weather Watchers All Sports CBS Sports HQ Patriots Red Sox Celtics Bruins Revolution Odds New England Living Question Everything It Happens Here Keller @ Large Wednesday's Child Climate Watch Change Makers Contact Us TV Schedule Meet Our Team Station Info Contests Jobs & Internships Download Our App Obituaries Watch CBS News Doctor says anyone using GLP-1 should focus on muscle-preserving strategies Millions of people are using GLP-1 medications to lose weight, but doctors say shedding pounds is just one part of the equation
Metallothionein 1 G and zinc sensitize human colorectal cancer cells to chemotherapy
